PMG
ADIL

Private Management Group’s Adial Pharmaceuticals ADIL Stock Holding History

Private Management Group’s Portfolio ADIL Stock Details ADIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-400
Closed -$2.2K – 312
2025
Q4 		$2.2K Hold
400
– – ﹤0.01% 310
2025
Q3 		$3.54K Buy
+400
New +$3.9K ﹤0.01% 295

Other funds holding ADIL

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
MCM
Manchester Capital Management Manchester, Vermont $768M AUM 29.32% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RWM
Raffa Wealth Management Washington, District of Columbia $793M AUM 13.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Private Management Group's ADIL Position: Q1 2026 in Review

Private Management Group sold out of Adial Pharmaceuticals (ADIL) in Q1 2026, closing a stake of 400 shares — an estimated $2.2K sold.

Private Management Group first reported a position in ADIL in Q3 2025 and held it in 2 quarters. The position peaked at $3.54K in Q3 2025. 15 funds tracked by Wall St. Rank hold ADIL as of Q1 2026.

  • Private Management Group reported no remaining Adial Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Private Management Group sold 400 Adial Pharmaceuticals shares in Q1 2026, an estimated $2.2K.
  • Private Management Group first reported a position in Adial Pharmaceuticals in Q3 2025 and held it in 2 quarters.
  • Private Management Group's Adial Pharmaceuticals position peaked at $3.54K in Q3 2025.
  • 15 funds tracked by Wall St. Rank held Adial Pharmaceuticals as of Q1 2026.

Based on Private Management Group's 13F filing for Q1 2026, filed 8 May 2026.